论文部分内容阅读
PET-CT-MRI triple fusion and its application in head & neck oncology : an alternative to integrated
【机 构】
:
Department of Nuclear Medicine & MRI, Rajiv Gandhi Cancer Institute & Research Centre Delhi, India
【出 处】
:
2nd Asian Nuclear Medicine Academic Forum & 3rd Rising NM Pr
【发表日期】
:
2016年8期
其他文献
Background: Fructose-1,6-biphosphatase (FBP1),a rate limiting enzyme,catalyzes the hydrolysis of fructose 1,5-bisphosphate to fructose 6-phosphate.Recently,some studies confirmed FBP1 can regulate gly
Background: Selective Internal Radiation Therapy (SIRT) is the treatment method for liver cancer by injecting Y-90 labled resin microspheres into the hepatic arteries supplying the tumor.
Evaluation of Tumor Specific Tracer targeting L-type Amino Acid Transporter 1 (LAT1): 18F-FBPA PET s
Background: 18F FBPA(4-borono-2[18F]fluoro-L-phenylalanine),an artificial amino acid tracer,is focusing attention as a tumor specific PET tracer to overcome the false positive cases of 18F-FDG in the
Background: Ferritin,an iron storage and transport protein,has been reported to serve as an intrinsic vehicle for targeting plaque macrophages.It is well known that macrophages play a key role in athe
Evaluating the response of Cisplatin treated VX2 tumor bearing rabbit lung cancer model by circulati
Background: The aim of the study is to evaluate the effects of chemotherapy by measuring the circulating cell-free tumor specific DNA (ctDNA) concentration and the tumor volume based metabolic paramet
Can We Predict Microvascular Invasion in HCC on FDG PET-CT? Can We Predict Microvascular Invasion in
Background: The purpose of this study is to correlate clinicopathologic and PET-CT parameters with the presence of microvascular invasion (MVI) at histopathologic examination (HPE) in patients with he
The semiquantitative parameters clinical usefulness of 18F-Fluorodeoxyglucose positron emission tomo
Background: The benefits of semi-quantitative parameters of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) and 111In-lbritumomab tiuxetan scintigraphy (111In-Zevalin) as therapeutic res